The store will not work correctly when cookies are disabled.
5-((5,7-Dioxo-5,7-dihydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-methyl)-N-hydroxy-[1,1'-biphenyl]-2-carboxamide
ID: ALA4784844
PubChem CID: 162666802
Max Phase: Preclinical
Molecular Formula: C21H15N3O4
Molecular Weight: 373.37
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NO)c1ccc(CN2C(=O)c3cccnc3C2=O)cc1-c1ccccc1
Standard InChI: InChI=1S/C21H15N3O4/c25-19(23-28)15-9-8-13(11-17(15)14-5-2-1-3-6-14)12-24-20(26)16-7-4-10-22-18(16)21(24)27/h1-11,28H,12H2,(H,23,25)
Standard InChI Key: KINRGHJMNNIEQN-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
31.0155 -16.4177 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.7220 -16.0070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4309 -16.4135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2718 -16.0887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9363 -17.2318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1375 -17.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7279 -16.6979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9132 -16.7004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5072 -17.4085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9218 -18.1156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7351 -18.1096 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.0989 -15.2863 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.4314 -17.2281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1395 -17.6345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8470 -17.2238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8419 -16.4024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1333 -15.9997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5565 -17.6293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5600 -18.4465 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.2624 -17.2177 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.9719 -17.6232 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.5450 -15.9920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2556 -16.3977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9602 -15.9852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9553 -15.1671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2400 -14.7634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5383 -15.1782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5439 -17.7784 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 1 0
4 7 1 0
6 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
4 12 2 0
3 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 3 1 0
15 18 1 0
18 19 2 0
18 20 1 0
20 21 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
16 22 1 0
5 28 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 373.37 | Molecular Weight (Monoisotopic): 373.1063 | AlogP: 2.66 | #Rotatable Bonds: 4 |
Polar Surface Area: 99.60 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.94 | CX Basic pKa: 1.66 | CX LogP: 2.30 | CX LogD: 2.29 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.42 | Np Likeness Score: -0.96 |
References
1. Mak JYW,Wu KC,Gupta PK,Barbero S,McLaughlin MG,Lucke AJ,Tng J,Lim J,Loh Z,Sweet MJ,Reid RC,Liu L,Fairlie DP. (2021) HDAC7 Inhibition by Phenacetyl and Phenylbenzoyl Hydroxamates., 64 (4.0): [PMID:33570940] [10.1021/acs.jmedchem.0c01967] |